Health and Human Services Secretary Robert F. Kennedy Jr. remains securely in his role over a year after his narrow 52-48 Senate confirmation in February 2025, driving trader consensus to a 75.5% implied probability against his departure by December 31. His April 16 testimony before House Ways and Means and Appropriations committees—defending Make America Healthy Again (MAHA) reforms, proposed budget cuts, and agency restructuring amid Democratic scrutiny on vaccines, staffing, and Medicaid—signals ongoing stability despite prior February staff shakeups and resignation calls from critics. Absent official resignation signals, dismissal threats, or scandals, traders view his position as resilient through year-end fiscal battles and 2026 midterms.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Piyasa Açıldı: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Health and Human Services Secretary Robert F. Kennedy Jr. remains securely in his role over a year after his narrow 52-48 Senate confirmation in February 2025, driving trader consensus to a 75.5% implied probability against his departure by December 31. His April 16 testimony before House Ways and Means and Appropriations committees—defending Make America Healthy Again (MAHA) reforms, proposed budget cuts, and agency restructuring amid Democratic scrutiny on vaccines, staffing, and Medicaid—signals ongoing stability despite prior February staff shakeups and resignation calls from critics. Absent official resignation signals, dismissal threats, or scandals, traders view his position as resilient through year-end fiscal battles and 2026 midterms.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular